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Abstract 
 
Phase behavior of Tri-block copolymer ( polyethylene oxide)a(polypropylene oxide)b( 
Polyethylene oxide)a, poloxamer 188, and  microstructure were studied in aternary system 
of  non polar Lime oil and water, the effect of temperature and addition of co-solvent and 
co-surfactant on tri-block copolymer behavior was also investigated in separate systems. 
The phase diagram of each system accomplished by drop wise titration method and 
constructed depending on the obtained results a five phase diagram of poloxamer 188, 
pharmaceutically acceptable  propylene glycol as a co-solvent  and Tween 80 and 
cremophor RH40 as a co-surfactant were obtained. 
 
The microstructure phases obtained from microemulsion systems characterized by visual 
inspection as well as cross polarizer were used to detect anisotropic properties. The clearly 
identified main phases obtained were gel, cubic, inverse micelles and normal micelles with 
clearly appearing the effect of addition of co-solvent and co-surfactant on the obtained 
phases on each system. The temperature clearly affects the behavior of poloxamer 188 with 
presence of co-solvent and co-surfactant by increasing the solubility in oil rich region of 
ternary phase diagram with increasing temperature.  
  
Enhance bioavailability of poorly water soluble Atorvastatin Calcium by constructing a 
microemulsion formulation depending on the behavior of poloxamer with biocompatible 
solvent and surfactant. The stability of Atorvatstain formulation tested for microemulsion 
properties and evaluated for clarity, precipitation, viscosity determination, and drug content 
by constructing analytical test method based on High Performance Liquid Chromatography 
(HPLC). The prepared formulations investigated through stability program including 
ambient and stress conditions of temperature and relative humidity for three months.  
 
Microemulsion as a topical drug delivery system for Hydroquinone prepared depending on 
the obtained results of microemulsion systems including poloxamer 188 as main surfactant. 
Each component in the formulation was properly selected for serving for both an effective 
component in microemulson formulation and achieving cosmetics objectives as skin 
compatibility, smell and perfuming characteristics, effective penetration enhancer and 
achieving customer compliance, beside ease of preparation and earning satisfaction for 
industrial point of view. The prepared formulations of Hydroquinone topical dosage form 
was investigated for clarity, precipitation, pH tests and viscosity determination. The 
stability results of Hydroquinone topical formulation obtained by investigating the 
formulation through stability program including ambient and stress conditions of 
temperatures and relative humidity with compliance of Palestinian Ministry of Health 
guidelines. The behavior and microstructure of tri-block copolymer can be involved in 
stable, compatible and safe products for pharmaceutical and cosmetics applications. 
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Chapter one 
Introduction 
 
1.1 Microemulsion 
 
Microemulsions are a thermodynamic stable isotropically clear dispersion of tow 
immiscible liquids such as oil and water stabilized by the interfacial film of surfactants 
with a combination of additives or co-surfactant. Microemulsions in comparison to other 
unstable dispersions such as emulsions or suspensions show advantages in terms of better 
solubilization potential and thermodynamic stability, since they are prepared by little 
energy input (heat and mixing) and have a long shelf life. The term microemulsion was 
first coined by Schulman group and still a rich scientific regain for research and 
magnificent finding till today.( Satya Priya and Animesh Kumar, 2006).  
 
 Some of the unique factors related to microemulsion are the presence of different texture 
such as oil droplets in water, water droplets in oil,  bi-continuous, lamellar mixtures which 
are formed by their  particular ability to significantly reduce interfacial tension (IFT) and 
enhance the solubilization of hydrophilic and lipophilic ingredients with aid of different 
factors such as electrolytes and temperature, in order to indicate the existence of these 
regions a phase study is constructed depending on the composition ratios. 
Construction of phase diagram can determine the aqueous dilutability and the range of 
composition of monophasic regions, the different structure formed by Microemulsions are 
typically classified into three main categories, or Winsor-type systems. (Lee, 2010). 
 
Winsor’s type I microemulsion consist of oil swollen micelles in water with excess water, 
where as a type II system consists of water swollen inverse micelles in oil with excess oil. 
Type III microemulsion system, middle phase microemulsion or Winsor III appears with 
an excess of both water and oil this type can be understood as an accumulation of all 
swollen micelles so they touch one another, forming some kind of percolated dispersion or 
a perfectly bi-continuous structure in which all water domains are connected and all oil 
domains are likewise connected. (Salager, et al. 2005).
 
 
Since microemulsion are not dispersions, the boundary between water and oil domains do 
not exhibit a strong curvature and the best microemulsion are formed with a zero-net 
curvature condition of the surfactant layer between the oil and water domains. 
Microemulsion which typically found in the center of a surfactant – oil – water (SOW) 
ternary phase diagram of Winsor type III which have a unique physicochemical 
formulation in which the affinity of surfactant for the oil phase exactly matches its affinity 
to water phase. This situation described by Winsor 50 years ago and has been referred to as 
“ optimum formulation”.  
To quantify the physicochemical formulation of SOW System many attempts have been 
made including phase inversion temperature, Hydrophilic – Lipophilic Balance (HLB), 
cohesive energy ratio and interaction energy ratio R, which was introduced by Winsor 
more than 50 years ago. (Salager, et al. 2005). 
To have a clear understanding of the ideas about Winsor work and the phase diagram as 
guideline map outlines the most important concept in the microemulsion phase and the roll 
of the surfactant in microemulsion systems, a simple description can be given to a ternary 
phase diagram system.  
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Figure 1. 1: Three types of phase behavior for surfactant (S), oil (O) and water (W) system 
according to Winsor ( adapted from Salager, et al. January, 2005).  
 
Figure  (1.1) Illustrate the three types of phase behavior for surfactant (S) – oil (O) – water 
(W) system according to Winsor. Shading areas indicate the surfactant rich phase, and R is 
Winsor ratio, that indicates the ratio of interaction between surfactants at interface and oil, 
and the interaction between surfactants and water. R= Aco/Acw . (Minana-Perez, 1995). 
 
 
In ternary phase diagram each of the vertices corresponds to each pure component : 
surfactant, oil and water, the composition of the particular mixture of the three component 
can be given as appoint inside the triangle. In case of Type I and Type II microemulsion 
system , figure (1.1) describes this simple clarification: 
 The dome in the lower part of the triangle represent two phases  - polyphasic- region and a 
SOW mixture inside the dome will separate in to two phases as indicated by the Tie-Line. 
 
 In Type I microemulsion the separation occurs in the side that produced excess oil in all 
the side of rich surfactant- rich aqueous phase and the composition of each phase can be 
determine by locating where the tie line intersects with the dome frontier it is called 
binodal curve. whereas the intersection of  Binodal curve and tie line closest to the water 
vertex is the surfactant rich water phase, where as the other intersection point in the other 
side is the oil excess. Conversely in a Winsor Type II two type phase region, the tie line 
slope is in the opposite direction and the surfactant rich oil is in equilibrium with excess 
aqueous phase.  
A Winsor Type III called middle phase microemulsion because it is located in intermediate 
in the triangle and contains the tie triangle and any point in the triangle will separate in to 
three phases, and the composition of the phases is independent where the plot of the tie 
triangle it’s proportional to the component of each corner of the triangle. (Salager, et al. 
2005). 
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Winsor introduced the ratio of interaction (R) between the surfactant, oil and water that 
form different phases in the diagram, by a relation described as: 
R= Aco/Acw 
where : Aco : Indicates the interaction between surfactant adsorbed on the interface and the 
oil phase per unit area of interface, and Acw is the same for water phase.  by this definition  
R equals 1 when middle phase microemulsion contains same volume of oil and water. 
When changes have been introduce to the system such as chemical changes which can be 
described as change the nature of one of the three components or a physical change such as 
change in temperature, salinity or pressure at least one of the interactions have to be 
changed , for example if the salinity in the aqueous phase in increases, by increasing the 
electrolyte concentration in water, the interaction of Acw is decreased and R will increased, 
resulting to increase uptake of oil in to the middle phase. (Salager, et al. January, 2005). 
 
When R=1 a maximum solubilization and a very low minimum interfacial tension are 
occurs.  
Figure (1.2) Illustrate phase behaviors along salinity scan test tube aspect and phase 
diagrams.  
 
 
Figure 1.2: Phase behavior along a salinity scan test tube aspect and phase diagrams. 
 (Adapted from Salager, et al. January, 2005).  
 
 
 
The figure describe a study on changing just one variable which is salinity, this is called 
the  formulation scan , and it is mostly used when changing one variable of the whole 
system, since this formulation scan can experimentally describe the best and special 
situation of having the interfacial tension goes to a very low minimum and solubilization 
reaches maximum when R= 1, the situation in which the formula take equal uptake of oil 
and water is known as the optimum formulation, this term is first designed by enhanced oil 
recovery (EOR) researchers but as work have to be applied in field the theoretical ideas 
have to approve its reality or some changes have to be introduced, as known in even for 
relatively simple systems there are much variables have to be considered so a correlation 
variables have to be introduced, these correlation are related to the free energy of transfer 
of a surfactant molecule from water to the oil phase (∆ Gw→o) this is also called surfactant 
affinity difference (SAD). (Kanicky, 2001). 
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Surfactant affinity difference (SAD): 
Ultra-low interfacial tension and maximum oil solubilization can be predicted using 
numerical empirical correlation. 
 
 SAD = µw - µo = ∆ G (w → o) = -RTLnKp 
 
Where µw and µo are the chemical potential of the surfactant in the water and oil phase, 
respectively. 
R in this case corresponds to the ideal gas constant. 
T is the temperature. 
Kp is the partition coefficient of surfactant between water and oil. 
 
This correlation (Surfactant affinity difference) is the measure of the difference between 
the Gibbs free energy of surfactant in the oil and water phase. SAD actually represents the 
free energy of transfer of a surfactant molecule from the water to the oil. 
 
Many factors can change the hydrophobic balance of the surfactants may enable movement 
from one type to another. These factors are illustrated below: 
1) Chain length of surfactants 
Longer chain length would transfer from Winsor I to Winsor II. 
2) Polarity of aqueous phase (Water) 
The addition of short chain alcohol can causes increase in polarity of water and then 
transfer from Winsor I to Winsor II. 
3) Temperature and electrolyte concentration  
The increasing in temperature for a non-ionic surfactants or increasing in 
electrolyte concentration for ionic surfactants would shift from Winsor I to Winsor 
II also. (Goodwin, 2004). 
 
The surfactant chosen must be able to lower the Interfacial Tension (IFT) to a very small 
values which facilitate the dispersion process during microemulsion preparation and 
provide a flexible film that can readily deform around the droplet and be of a appropriate 
lipophilic character to provide the correct curvature at the Interfacial regions.   
Many numerical equations can be used to calculate the values of interfacial tension (IFT), 
scientist Huh (1979) develop an equation that used to estimate IFT using optimal solubility, 
this equation is given as: 
 
γ = 0.3 / (σ*)2   
 
where γ is IFT and σ* is oil or water solubilization ratio at optimal salinity. (Flaaten, 
2007). 
 
Another research indicates that interfacial tension can be calculated using Vannegut 
equation (1942): 
 
γ  = π (ρ1 – ρ2) Rd
3 ω2 / 4 
 
γ = Interfacial tension 
ρ1= Density of continues phase 
ρ2= Density of droplet phase 
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Rd = Droplet diameter 
ω = Rotational speed. (Flaaten, 2007). 
 
All the above results of scientific research where obtained to ease the dealing of IFT values 
in equation forms, since these values are of great importance in microemulsion techniques. 
 
Microemulsion as a technique has increasing interest in all scientific approaches, mixing of 
water, oil and surfactant or mixture of surfactants, to get special formulation proper for 
certain branch in industry, cosmetics and pharmacy  products is the riches area for 
research. The most important properties of microemulsion such as ultralow interfacial 
tension, small micelles size, transparency, are the most driving forces for searching for 
good, stable and multipurpose microemulsion formulas. 
Preparation of microemulsion to ease the solubility of  non polar oils in such formulation 
and get a maximum solubilization is the global idea of microemulsion application, and the 
logical ways to enhance the solubilization is the increase in interaction of the surfactant for 
both the oil and water phase, which can be achieved by carefully increasing the volume for  
both the head and the tail of the surfactant molecule, or addition of molecules that bridge 
the adsorbent surfactant layer and the bulk phase, and this is accomplished by using 
lipophilic and hydrophilic linker effect, this linker result in what is called extended 
surfactant, or using  block copolymer additives, this is what is the most interesting idea in 
using a type of polymers a  tri-block co-polymer known by many names such as 
poloxamer, Pluronics, synbyronic, or Lutrol.  
polymers have a great attention in recent years as a main component in microemulsion 
formulation as main surfactant or as co-surfactant , the Surfactant polymer interaction have 
been long studied in various application ranging from detergency to enhance oil recovery, 
to drug and gene delivery. Many different factors affecting the interaction. The type of 
surfactant ( ionic, nonionic, cationic), surfactant chain length, the ionic strength of aqueous 
phase. this interaction activate each part of the new complex to be more effective than the 
parent component. (Monica, et al.  2008). 
Microemulsion has emerged a prospective approach in cosmetics industry, since the 
formulation can incorporate a large amount of lipophilic cosmetics actives in to the inner 
oil phase. Due to the small droplet size and large amount of inner phase, the density of 
droplets and their surface area are assumed to be high, therefore the droplet settle down to 
close contact with skin providing high concentration gradient and improve permeability , 
moreover low surface tension ensure good contact to the skin. The surfactant and co-
surfactant in the microemulsion can reduce the diffusion barrier of the stratum correnum by 
acting penetration enhancers and facilitating cutaneous penetration. (Adnan, et al. 2008)   
1.2 Characterization of Tri-block copolymer” Poloxamer” 
Polymers are substances of high molecular weight made up of repeating building units 
known as monomers, used in pharmaceuticals applications as suspending agent, 
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emulsifying agent, adhesives, coating materials, a components in controlled release dosage 
forms, and in site specific or targets dosage forms as a drug delivery system. 
 The chemical reactivity of the polymers determined by its monomer units chemical 
reactivity, polymers could be linear or branched in their molecular shape, polymers in 
which all their monomers are identical are identified as homo-polymers, and those formed 
from more than one monomer type are  identified as copolymers. Copolymers may be 
described as alternating copolymers, block copolymers, or graft copolymers. Pluronic is 
one of the most widely used block copolymers. (Florence, 1998). 
Tri- block copolymer known for BASF chemical corporation are used under name of 
pluronic or poloxamer are available as di-functional block copolymers of non-ionic nature 
comprises from a central block of relatively hydrophobic polypropylene oxide surrounding 
on both sides by the blocks of relatively hydrophilic polyethylene oxide.( Jakobs, et al. 
1999). Due to this unique structure poloxamers can form different micelles structures when 
immersed in different solvents, especially when the solvent is selective for the building 
block of the polymer. (Alexandridis, et al. 1995). 
The polymerization process  define the molecular weight distribution of the polymer, 
during the polymerization process of propylene oxide block  a fraction of propylene oxide 
may change to allyl alcohol which farther will react with propylene oxide and ethylene 
oxide forming polymeric material, with half molecular weight of the final wanted product, 
this segment leads to unsaturation part of the poloxamer. Finally  the reaction terminated 
by hydroxyl group so no farther reactions will occur and polymerization process stopped. 
(Guiader, 2005).   
 The following figure describe polymerization process of the poloxamer: 
 
Figure 1.3:  Description of the polymerization process of Poloxamer (Guiader, 2005).   
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poloxamers have the structure:  HO(C2H4O)a(C3H6O)b(C2H4O)aH, where a and b are 
block with following values (Hand Book of Pharmaceutical Excipients, 2009): 
Table (1.1): Types of Tri-block Copolymer. 
Pluronic Poloxamer a b Ave molecular weight 
F127NF  407 101 56 9 840–14 600 
F108NF 338 141 44 12 700–17 400 
F87NF  237 64 37 6 840–8 830 
F68NF  188  80  27 7 680–9 510 
L44NF  124 12 20 2 090–2 360 
 
These Tri-block copolymers listed above have specifications which are conformed to the 
monograph of the official requirements for different international references such as United 
Sates Pharmacopoeia, British Pharmacopeia, European Pharmacopeia, and Hand Book of 
Pharmaceutical Excipients, even there is five grades of poloxamer are listed on United state 
pharmacopeia, there is other commercial grades of poloxamer. (Hand Book of 
Pharmaceutical Excipients, 2009) 
Table (1.2): Specification of Tri-block copolymer.  
Specification Tri-block copolymer 
124 188 237  338  407 
Physical Form Liquid Solid Solid Solid Solid 
pH, 2.5% aqueous 5.0 – 7.5 5.0 – 7.5 5.0 – 7.5 5.0 – 7.5 5.0 – 7.5 
Cloud point, 10% 71–75C >100 C >100 C >100 C >100 C 
H2O% 0.4 max. 0.4 max. 0.4 max. 0.4 max. 0.4 max. 
BHT, ppm – 50– 125 50– 125 50– 125 50– 125 
Weight % oxyethylene 46.7 ± 1.9 81.8 ± 1.9 72.4 ± 1.9 83.1 ± 1.7 73.2 ± 1.7 
Ethylene Oxide, ppm 1 max.  1 max.  1 max.  1 max.  1 max.  
Propylene Oxide, ppm 5 max 5 max 5 max 5 max 5 max 
1,4 dioxane, ppm 5 max 5 max 5 max 5 max 5 max 
Heavy Metals, ppm  2 max. 2 max. 2 max. 2 max. 2 max. 
Melting point 168C 52–578C 498C 578C 52–578C 
Density at 258C (g/cm3) 1.06  1.06  1.06  1.06  1.06  
Flash point  260C 260C 260C 260C 260C 
Solubility in water and 
ethanol ( 95%) 
Freely 
Soluble 
Freely 
Soluble 
Freely 
Soluble 
Freely 
Soluble 
Freely 
Soluble 
HLB Value 12 - 18 > 24 > 24 > 24 18 - 23 
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The chemical structure of pluronics described on the following figure:  
 
 
Figure 1. 4: Chemical structure of pluronic (adapted from reference (Guiader, 2005).  
 
Poloxamer can be available in micronized particle size, BASF Corporation are the leading 
company in worldwide marketing of all grades of  tri-block copolymers have developed a 
new type of tri-block copolymers  which are Lutrol micro 68 and Lutrol micro 127 to 
enhance the solubility of poorly water soluble drug. 
 
of special grades of  Lutrol F68 known as microprilled Lutrol  F68  with much effective 
properties related to Average particle size of 50 micron, Stronger solubilization activities, 
Controlled dissolution rate, Achievement of homogeneous blend, Elimination of dose 
dumping, Effective water soluble lubricant all of these newly attractive properties are 
developed to ease the  use of tri-block copolymer in all application. Some application of 
Lutrol F68 in pharmaceutical applications Lutrol F 68 is primarily applied as an emulsifier, 
solubilizers, and suspension stabilizer in liquid oral, topical and parenteral dosage forms. In 
solid preparations it acts as wetting agent, plasticizer, and to enhance the solubility and 
bioavailability of sparingly water soluble active drugs. And due to its low toxicity, it is 
proved to be a very useful excipient, even for parenterally applications. Also the unpleasant 
taste or smell of actives pharmaceutical materials can be masked by either using polymeric 
film formers or Lutrol F 68 alone or by combining it with hydrophobic compounds. 
(Guiader, 2005).   
All types of tri-block copolymers have been introduced to many different projects and 
many research papers have been published including their behavior and the influence of 
addition solvent, co-surfactant and temperature on their behavior. 
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1.3 Lime oil: 
  
Lime oil and Lemon oil are natural oils used as flavoring and fragrance raw material in 
many products, the flower and the fruits of lime could be used to extract the juice. Whereas 
the fruits and the trees of lime is different from lemon oil, it is first known in Asia,  known 
on International Nomenclature of Cosmetic Ingredients (INCI) as Citrus Aurantifolia and 
has CAS#: 8008-26-2, ( International Cosmetic Ingredient Dictionary and Handbook 2000, 
1999).the specification of Lime oil is listed in the table below as acoording to(Sciencelab, 
2011). 
Table (1.3): Specification of Lime oil. 
 
Specification  Limit 
Color Colorless to Greenish yellow 
Odor Intense fresh citrus 
Solubility Insoluble in water and soluble in organic solvent as ethanol 
and in propylene glycol 
specific gravity of oil Between 0.855 to 0.863 
optical rotation   +34 to +47 
Storage Condition Sensitive to both air and light so the oil has to be tightly kept 
and in amber bottles 
 
The extracted lime used  in different products in food , drinks, Herbal, the Lime flower is 
listed by the Council of Europe as a natural source of food flavoring ( category number 2, 
which indicate the product can be added to food stuff in small quantities, and categorized 
as safe product. In herbal uses the lime flower extract are uncountable as in arteriosclerotic 
hypertension, feverish colds, and specifically for raised arterial pressure associated with 
arteriosclerosis and nervous tension. It has reported to possess a restricted range of 
antifungal activity. (Gurin and Reveiller, 1984). 
Several processes are used to produce lime oil. Expressed lime oils are produced by 
pressing the ripe fruits by sponge-press (by hand) or machines. These oils may be produced 
more economically using an integrated juice-oil procedure such as the Brown Oil 
Extractor,  where citrus fruit is partially submerged in water and abraded by metal discs. 
The oil is separated from the juice as a water-emulsion, and further separated using 
centrifugation. (Swaine, 1988). 
 Lemon and Lime oils are also produced by distillation of expressed oils or direct 
distillation of fruit. oils are distilled for removal of terpenes in order to improve solubility 
and permit use for flavoring carbonated beverages, the oils can be steam distilled to 
remove nonvolatile furocoumarins and marketed as “ psoralen free” .( Burdock,1995).   
The photo toxicity of lemon and lime oil  has been clarified and investigated using samples 
obtained from different geographic locations, studies have investigate the phototoxicity of 
a large number of fragrance raw materials including lemon oil and lime oil. Fragrance raw 
materials were tested using humans, pigs and albino, hairless mice. Several irradiation 
sources were used including sunlight, a solar simulator and a UVA radiation. Expressed 
lime oil was phototoxic in all three species under all three radiation sources. But Distilled 
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lime oil presented no phototoxic response in any species, which is a great results indicate 
the safety of using the oil by identifying the type of extraction. (Forbes, et al.1977). 
1.4 Atorvastatin Calcium: 
 
Atorvastatin is a member of drugs known as statins used for lowering blood cholesterol, it 
is an inhibitor of 3-hydroxy-3-methylglytarylcoenzyme A ( HMG-CoA) reductase. This 
enzyme catalyzes the conversion of HMG-CoA to mevalonate, an early and rate limiting 
step in cholesterol biosynthesis. Atorvastatin calcium is salt form of the atorvatstain active 
pharmaceutical ingredient, is a white to off white crystalline powder that is insoluble in 
aqueous solution of pH 4 and below, very slightly soluble in distilled water, pH 7.4 
phosphate buffer, and acetonitrile, slightly soluble in ethanol and freely soluble in 
methanol. 
 
Atrovastatin calcium is [R-(R*, R*)]-2-(4-fluorophenyl)-(beta),[dgr]-dihydroxy-5-(1-
methyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid, calcium salt 
(2:1) trihydrate. The empirical formula of atorvastatin calcium is  
(C33H34FN2O5)2Ca.3H2O and its molecular weight is 1209.42 its structural formula is:  
 
 
 
 
Figure 1.5: chemical structure of atorvastatin calcium ( adapted from PDR, 2006).   
  
The Intestinal permeability of Atorvastatin is high as at the physiological intestinal pH 
ranging (6.0 – 6.5). It is reported that the absolute bioavalability of Atorvastatin is about 
12% after a 40mg of oral dosage form. from the chemical structure of Atorvastatin the pKa 
of Atorvastatin’s terminal carboxylic group is 4.5, theoretically , the solubility and 
dissolution rate of Atorvstatin calcium is markedly improved at pH values equal to or 
greater than( pKa + 1). The pH of the gastric environment equal or greater than 5.5, so an 
enhancement in the dissolution and bioavailability can be suggested through formulation 
with pH ranging more than 5.5. (Salam and Dumitru, 2009).  
 
The oral bioavailability of atorvatstain is limited by many conditions such as the membrane 
permeability, the solubility, and the dissolution rate which treated as a critical factors for a 
sparingly water soluble drug. Many approaches have been developed to improve the 
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solubility of and enhance the dissolution rate and oral bioavailability of poorly soluble 
Atrovastatin like, salt formation, Solid dispersion, including complex agents, 
microemulsion, micronization, and self emulsifing drug delivery system. 
Physical modification aims to increase the surface area, solubility and wettability of the 
powder particles and therefore focusing on particle size reduction or generation of 
amorphous states of the active pharmaceutical ingredients. 
  
Atrovastatin is usually used in its calcium salt as a conventional active in solid dosage 
forms. Also it can exist in an amorphous form and in many crystalline forms, the main 
difference between these forms are the dissolution characteristics and bioavailability of the 
drugs. to have uniform from an amorphous form only of the powder of atorvastatin 
additional process parameters have to be added which resulting in 5 – 10 % loss in the final 
amount of atorvastatin calcium, which reduces the economically production process since 
atorvastatin calcium is an extremely expensive substance. (Salam and Dumitru, 2009). 
 
Atorvastatin calcium is presented as solid tablet dosage form for oral administration, 
present in strength of 10, 20, 40 and 80 mg per tablet, marketed under trade name Lipitor 
by Pfizer.(PDR, 2006).  
    
1.5 Hydroquinone:  
 
Hydroquinone is 1,4-benzenediol. It CAS number is [123-31-9]. Hydroquinone is structurally 
related to monobenzone. Hydroquinone occurs as fine, white needles. It is freely soluble in water 
and in alcohol with a pKa of 9.96. Chemically, hydroquinone is designated as p-dihydroxybenzene; 
the empirical formula is C6H6O2; molecular weight 110.1.The structural formula is: 
 
 
Figure 1.6: Hydroquinone Structural Formula [adapted from USP 34] 
 
The USP- 34 assign the limit of melting range of hydroquinone as raw material is between 
172 – 174C, the limit of water content: is not more than 0.5% and the limit of residue on 
ignition is not more than 0.5 %. The critical point in dealing with hydroquinone is its photo 
stability it has to be stored in a well closed light resistance containers. (USP-34)  
 
Hydroquinone used in many products due to its properties as a water-soluble reducing 
agent. It is used in medicine (up to 5% in concentration) to treat dyschromias (as  melasma, 
an acquired hypermelanosis) and in cosmetics (up to 2%) as a depigmenting agent in a 
number of topical skin creams. It may present as gel, cream or solution for topical 
purposes. (U.S. Food & Drug Administration, 2009). 
  
The main use of hydroquinone as bleaching and defragmentation product has given it a 
worldwide good presentation and has a high customer satisfaction values since it has a 
great effect within the usage period. The main side effect of the products containing 
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hydroquinone that they may cause irritation and as a drug the usage period have to be 
controlled and not exceeding the prescription dose. (Saraf, et al, 2012).    
 
Different approaches contributed in preparation hydroquinone for topical use, the most 
known techniques are microemulsion, micro-sponge, liposome. The most interesting 
properties of using microemulsion over other techniques are: 
 
The ease of preparation, long stability, higher ability of drug loading, can be applied for 
polar and non polar actives, can be applied in diverse dosage form as creams, lotions and 
pastes, can maintain compatibility and preventing irritation to sensitive skin, compatible to 
divers vehicle and component and achieving customer satisfaction. (Saraf, et al, 2012).    
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Chapter two 
Literature review 
 
Tri-block copolymer of polyethylene oxide and polypropylene oxide often denoted by 
PEO-PPO-PEO are water soluble and commercially available as nonionic macromolecule 
surfactant, these tri-block copolymers commercially marketed worldwide because it meets 
the requirements and achieve the optimum specification and required properties related to 
variation of molecular characteristic depended on PPO\PEO ratio.  
Tri-block copolymers are an important class of surfactant and find widespread industrial 
application in detergency, dispersion stabilization, foaming, emulsification, lubrication, 
and in more specialized application in pharmaceutics such as: drug solubilization and 
controlled release, in bio-processing, as a delivery system and as a drug targeting system. 
There are interesting research targeting tri-block copolymers this chapter will summarize 
some of these great research. 
 
Tri-block copolymers like any other surfactants, when dispersed in solution or liquids at 
low concentrations it exist individually, forms monomolecular micelles, this leads to 
decrease in the surface tension, as the concentration increases the polymer forms multi-
molecular aggregates. The structural properties of the tri-block copolymer offers unique 
properties, the propylene oxide forms hydrophobic cores where methyl groups interacts by 
Van der waals forces with medium going solubilization. Water solubility of tri-block 
copolymers due to hydrogen bonding of polyethylene oxide (PEO) block with water, 
interaction of ether oxygen with water, these interactions strength tri-block copolymers to 
become soluble in both polar and non-polar solvents. The aggregation forms of tri-block 
copolymers depend on many properties as the molecular weight of these polymers, the size 
of the blocks, the temperature and the solvent components.(BASF, 2010).  
Average Molecular weight of tri-block copolymer, determined by the molecular weight of 
PPO and PEO blocks, affects the main concept of polymer behavior as critical micelles 
concentration (CMC) and critical micellization temperature (CMT). (BASF, 2010).   
(Alexandridids, et al. 1994) published a study on the Critical Micellization temperature 
(CMT) and Critical Micellization Concentration (CMC) of 12 types of tri-block copolymer 
from thermodynamic point of view. It was determined that the micellization process is 
entropy driven and has an endothermic micellization enthalpy. It was found that the 
hydrophopic part of co-polymer (PPO), was responsible for the micellization, due to 
dehydration of hydrogen bonding between water and PPO with increasing temperature. 
The Critical Micellization Concentration (CMC) dependence on temperature and size of 
head group ( PEO) of copolymer follow the same trend as with lower molecular weight of 
nonionic surfactant were as the effect of temperature a appeared more pronounced with 
copolymer. 
  In another published work for (Alexandridis, et al, 1995) Confirmed the effect of 
temperature increasing on  micellization behavior in aqueous solution of copolymer as 
temperature increases, the proportion of dehydrated methyl groups of polymer increases. 
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This indicates that methyl groups are experiencing less polar environment and the 
interaction of methyl groups with water molecules is weakened by heat. 
(Wanaka, et al. 1999). Studied the phase diagrams of different types of copolymers and 
confirmed that a liquid micellar phase is stable at low temperatures but transforms into the 
cubic structure by increasing the temperature usually there is a broad temperature region of 
about 20C in which the transformation occurs. At higher concentrations and temperatures 
solutions with spherical micelles form in a first order transition, a transparent, optically 
isotropic, highly viscous, and elastic cubic phase are observed. The formation of this cubic 
explained as hard sphere interactions between the aggregates; with farther increasing 
concentrations transitions to hexagonal and to lamellar phases are observed.  
Samples with a smaller hydrophilic EO block, usually forms a hexagonal phases as the first 
liquid crystalline mesophases. While samples with moderate or high hydrophilic EO block 
a lamellar phases is found as the first mesophase. These mesophase usually melt at 
temperature below 100 C.  
 
Micellar solution of tri-block co-polymers have been investigated using many different 
techniques including: NMR, Static and dynamic light scattering, rheology, fluorescence, 
using these techniques a lot is known about the properties of the micelles, and as a 
conclusion measurements obtained by these techniques determine that the core of the 
micelles consists of PO groups. The core of the micelles is assumed to be free of water, 
while the EO groups still hydrated. 
 The solvent quality has a major and controlling factor of block copolymer, while a number 
for PPO selective solvent have been tested; water is the only selective solvent for PEO 
block always used. The solvent selectivity of water for PEO and PPO can be altered by a 
change in temperature or addition of co-solutes such as alcohols or salts any of these 
factors has great effect on micellar behavior of poloxamer, it is desirable to replace water 
completely by a non-aqueous polar solvent for some application in which the presence of 
water is no longer wanted because of many problem such as corrosion possibility.   
(Alexandridis, 1998).studied the behaviors of copolymers in non aqueous polar solvent. 
The considerations have been motivated towards many solvent such as hydrazine, 
formamide, N-methylformamide, glycerol, propylene glycol, and ethylene glycol. The 
research indicate the effect of formamide on the tri-block copolymer, since nonionic 
polymers found to form micelles and even lyotropic liquid crystalline structures in 
formamide over different conditions more than in water. It was reported that the tri-block 
copolymer can self assembly in to six different thermodynamically stable microstructure, 
and at higher co-polymer concentrations a region of hexagonal, bicontinous cubic and 
lamellar lyotropic liquid crystalline structures are stable. And the stability region of 
different structures are shifted to higher polymer concentrations and temperature compared 
to using water as a solvent, suggesting that the effect of effective curvature of the interfaces 
formed by block co-polymer is higher in formamide than in water.  
Alexandridis, et al. 1998 observe The richest structural polymorphism, in equilibrium, in 
mixtures containing block copolymer, the self assembly of PEO/PPO block copolymer can 
vary from normal (oil in water) micelles in solution, through all types of normal and 
reverse ( water in oil) lyotropic liquid crystals( normal micellar cubic, normal hexagonal, 
normal bicontinuous cubic, lamellar, reverse bicontinuous cubic, reverse hexagonal, 
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reverse micellar cubic), to reverse micelles. The structure in the liquid crystalline phase 
have been investigated by small angle X-ray scattering ( SAXS) and as a conclusion this 
diverse microstructure of tri-block copolymer is of great importance to numerous practical 
applications, this ternary system used as a reference in all poloxamer studies relating to 
phase behaviour  
The figure below indicates the ternary phase diagram obtained:  
 
 
Figure 2.1: A ternary Phase diagram of Tri-block copolymer, Xylene and Water.  
Svensson, et al. 1999 explained the result obtained by Alexandridis, et al. 1998 using 
Lattice mean- field theory model to account for temperature dependent solubility of the 
blocks consisting the copolymer. The calculation involved free energy determination of the 
phases obtained in the phase diagram, it was observed that with increasing length of the EO 
block the reverse phases become unstable; the size increase of the water soluble EO block 
favors structures with curvature towards polar domain which is normal structure.  
Ivanova, et al., presented a useful study of ternary isothermal (25C) systems of pluronic 
F127 in presence of various co-solvents such as water and polar water miscible solvents 
like glycerol, propylene glycol and ethanol, and a partially water immiscible solvent like 
glycerol triacetate and in the presence of surfactants like sodium dodecyl sulphate and cetyl 
trimethyl ammonium bromide using Small Angle X-ray Scattering (SAXS) addresses the 
co-solvent/ surfactant effects in the phase behavior of the polymer.  
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The study indicate that the effects of different co-solvent or surfactant affect  the 
poloxamer phase behavior, it was found that organic solvent, depending on their relative 
polarity, locate preferably in the PEO rich or the PPO rich domains of the microstructure. 
Some solvent as ethanol and glycerol triacetate may show amphiphilic behavior and act as 
co-surfactants and preferably locating at the interface between the PEO rich and the PPO 
rich domains. 
The location of the solvents in the block co-polymer assemblies is established by an 
analysis of the trends in the structure lattice spacing obtained from SAXS and the 
interfacial area per block copolymer molecules. In general increasing the solvent polarity 
will increase the solvent preference to locate in the relatively a polar PPO- rich domains, 
and hence increases the variety of the microstructure  obtained from block copolymer but 
decreasing their stability range. (Ivanova, et al. 2001). 
 Frank, et al., studied the properties of mixture of two poloxamer grade of the most popular 
research focused on the micellization and gellation of two poloxamer F88 and poloxamer 
P85 in water by use of DSC, SAXS and Rheology. Micellization was mainly characterized 
by DSC, where as gellation was studied by SAXS, and macroscopic behavior was 
characterized by Rheology. It appears that micellization was followed by gellation for 
sufficiently concentrated samples. The results of behavior of Mixture of poloxamer show 
that the gellation temperature of the poloxamer mixtures was enhanced by more than 10C 
with respect to gelltaion temperature of the parent poloxamer, so it can be concluded that 
the mixture composition is an alternative method to modulate the gellation temperature and 
gel structure, and this behavior seems promising as a model for pharmaceutical application 
which targeting drug within poloxamer gel. 
As the tri-block copolymer show divers polymorphism interesting research published by 
Kraranikolos, et al. 2008 using stabilized templates of pluronic P105 in the synthesis of 
optically active semiconductor nanostructures with controlled shape and size. The system 
exhibit well defined structural order at the nano-scale consisting of spherical, cylindrical or 
planar microdomains. For the growth of nano-crystals depending in to two steps the first 
components of the crystals (group II elements) was obtained by introducing the metal by 
dissolving into the dispersed phase of the templating system and then a hydride gas reacted 
with pre-composed part of the semiconductor already contained in the block copolymer. 
These steps lead to nucleate nano-crystal growth inside the block copolymer domains. 
Coalescence among the domains is slow due to stabilization induced by the long polymeric 
chains at the interface of each domain and this resulting in long-term stability of the 
encapsulated nano-crystals. The main critical parameters in nano-materials are particle 
size, shape, composition and growth environment and all can be controlled by self 
assembly of tri-block copolymers in selective solvents. Compounds semiconductor 
quantum dots, nanowires, nanotubes, hollow spheres, and two dimensional nanostructures 
were grown at room temperature in the self assembled tri-block copolymer. 
Karanikolos and Alexandridis reported a techniques for controlled synthesis of ZnSe 
semiconductor nanostructure by using cubic, hexagonal and lamellar lyotropic liquid 
crystals as templates, the liquid crystal were formed by self assembly in ternary system 
consisting of a pluronic P105 amphiphilic block copolymer  as the surfactant, heptanes as 
the non-polar dispersed phase, and formamide as the polar continuous phase.  
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ZnSe quantum dots and nanowires with diameter smaller than 10 nm were grown incide 
the spherical, cylindrical and planar nanodomains by dissolving diethylzinc in heptanes 
domains and reacting the domains with hydrogen selenide gas that brought into contact 
with liquid crystal in a sealed chamber at room temperature and atmospheric pressure. 
Tri-block copolymer are superior candidates component for microemulsion in 
pharmaceutics application, using microemulsion as a drug delivery system for the purpose 
of improving the solubility and oral absorption of poorly water soluble drug, has attract 
much attention in recent years. Microemulsion system has shown to improve absorption  of 
drugs due to small droplet size and promotes intestinal lymphatic transport  due to its 
specific components. Atrovastatin is one of the drug which need to enhance its 
bioavailability since it is a poor water soluble drug and has a low bioavailability due to 
rapid metabolism in the gut and liver, since Intestinal permeability is necessary for oral 
administration so microemulsion as a drug delivery system is promising approach to 
enhance the solubility and oral absorption of Atorvastatin. A lot work have been done on 
enhancement of atorvastatin bioavailability. 
 
Surjyanarayan, et al., designed and develop microemulsion drug delivery system of 
Atorvastatin and investigate it intestinal transport behavior using the single-pass intestinal 
perfusion method in rat. The permeability behavior of Atorvastatin over three different 
concentration ( 10, 20, 40 µg/ ml) was studied in each isolated region of intestine  
(duodenum, jejunium, ilume and colon) of rat. The human intestinal permeability was 
predicted using Lawrence compartment absorption model. It was reported that the particle 
size of microemulsion was 18.3 ± 0.3nm and there was no significant differences between 
the permeability of the intestinal regions, the estimated human intestinal permeability was 
relatively higher. 
 
Shun-Ji, J. et al., prepared self-micro emulsifying drug delivery system (SMEDDS) 
incorporating atorvastatin calcium  and evaluate its properties and oral bioavailability. The 
main droplet size of optimized formulation ( 20% ethyl oleate, 40% tween 80, 40% 
Carbitol) was 23.4 ± 1.3 nm. The prepared system appeared to give better dissolution 
performance studies, compared with raw atorvastain calcium, the release percentage of the 
prepared system could easily reached more than 95% within 3 minutes which significantly 
is very high compared to raw atorvastain calcium. The prepared system was relatively 
stable when stored at 4ºC during 3 months. 
 
 Lee, D. et al., prepared self-microemulsifying drug delivery system for oral bioavailability 
enhancement of Atorvastatin calcium. The release rate of atorvastatin calcium from 
SMEDDS was investigated in gastric juice at pH 1.2 and intestinal juice at pH 6.8. The 
concentration of atorvastatin calcium was quantified by high performance liquid 
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chromatography. The main result f the study were the optimized formulations for in vitro 
dissolution and bioavailability were capryol 90 40%, cremophor EL 38.7%, and carbitol 
19.3 %, the average droplet size distributed was 21.6 nm. The release rate of atorvastatin 
calcium was  higher than conventional marketed tablet. 
 
Pawan, K.  et al., formulated  a self-emulsifying drug delivery system of Atorvasttain 
calcium and its characterization including in-vitro and in-vivo studies, The optimize 
formulation was using  Captex 335 as the oil, campul MCM and tween 80 as surfactants 
mixture, and PEG400 as co-solvent, the best ratio of surfactant was 4:1 wt/wt, the optimize 
formulation was evaluated for microemulsifying properties and tested for clarity, viscosity, 
drug content, and in-vitro dissolution and stability study, the formulation significantly 
reduced serum lipid levels as compared with raw material. 
 
Hai Rong Shen and MingKang Zhong prepared a SMEDDS containing Labrafil as an oil, 
Cremophor RH40 as surfactant and propylene glycol as co-surfactant, and use it as a 
formulation to increase the dissolution and permeability of drug by significantly decrease 
the droplet size to less than 100nm, the prepared SMEDDS might have the potential to 
improve the oral bioavailability of atorvastatin compared to traditional marketed tablet.  
 
 Guohui, et al. recently study the inclusion of Poloxamer 188 as an effective agent in 
sealing permeabilized cell membranes. In the cases of diseases such as electrical shocks, 
radiation injuries, and thermal burns which can all lead to a loss of the integrity of the cell 
membrane which can immediately defect the essential role of the cell membrane as a 
barrier and affecting its control over the transport of materials into and out of the cell.  
 
Poloxamer 188 was the first in the family of tri-block copolymers to be tested as a 
candidate for membrane sealant, primarily because it had been widely used in medical, 
pharmaceutical and cosmetic systems as a solubilizing, wetting and emulsifying agent with 
low toxicity. To identify  the molecular mechanisms of interaction between Poloxamer 188 
and damaged membranes, a monolayers phospholipid as a model for the outer leaflet of the 
membrane naturally found in humans have been treated with Poloxamer 188.  Using X-ray 
and fluorescence microscopy measurements, it was found that Poloxamer 188 changes the 
phase behavior and morphology of the lipid monolayers. P188 inserts into monolayers 
phospholipids components and the results indicate that Poloxamer188 insertion is without 
influencing by head-group electrostatics of phospholipids of the layers. As a result the 
poloxamer selectively adsorbs into damaged portions of membranes and localizing its 
effect. This combination of techniques is used for the first time to investigate the 
lipid/poloxamer interactions as a technique to help the membrane to regain its barrier 
function so the cell heals and reestablishes its normal lipid packing density.  
In another topic of using poloxamer in pharmaceutical application, Hitesh, et al. published 
that poloxamer 188 has been found to protect against tissue injury in various experimental 
models by decreases inflammation and tissue damage after experimental brain injury in 
21 
 
rats.  A study was made on 6 rats which were treated by poloxamer 188 after experimental  
injury, the results obtained from the animals assure that Poloxamer 188 has a great effect 
on preventing inflammation and tissue loss after the injury, these results seems remarkable 
in using poloxamer as a healing model after medical injury.  
New type of study relating about DNA-loaded nanoparticles, done by  Csaba, et al., 2006. 
Its  emission is delivering DNA molecule as nanocapsulated forms through cell membrane 
without any defect or loss using various polymer blends. In vitro cellular uptake plasmid 
DNA nanoencapsulated in pluronic F68 and other polymer blend particles were studied. In 
vitro cell culture studies showed that nanoparticles enter the cells and cause transportation 
of DNA across the membrane. Fluorescent nanoparticles in in-vivo studies showed that 
they are able to overcome nasal mucosal barrier. In the case of immunization studies, 
DNA-loaded nanoparticles show fast and strong response, more marked than naked 
plasmid DNA for up to 6 weeks. This shows that these nanoparticles carrier serve to be 
efficient carriers for delivery of DNA across the nasal mucosal membrane. 
With increasing competition and needs for customer compliance, innovations gained a lot 
of importance in cosmetic delivery systems. Conventional formulations of topical drugs are 
intended to work on the outer layers of the skin. Typically, such products release their 
active ingredients upon application, producing a highly concentrated layer of active 
ingredient that is rapidly absorbed, providing a short duration of action but more serious 
side effects can occur when active ingredients penetrate the skin as irritation and allergic 
reactions and burning in significant users.  
The application of topical drugs has many problems like greasiness, stickiness associated 
with the ointments that often result in lack of patient compliance. All of these 
complications could be overcome by using a unique, versatile and novel approach 
microemulsion in drug delivery system, especially when dealing with sensitive active 
material as Hydroquinone.   
 
A lot of research focused on using micosponge approach for delivering Hydroquinone for 
topical use. Microsponge technology allows an even and sustained rate of release, reducing 
irritation while maintaining efficacy. (Saraf, et al, 2012). 
 
SkinMedica Incorporation manufacture and market a EpiQuin Micro, which is a product 
based on  Microsponge system uses microscopic reservoirs that entrap hydroquinone and 
retinol. The Microsponge delivery system releases these ingredients into the skin gradually 
throughout the day. This provides the skin with continuous exposure to hydroquinone and 
retinol over time. (Grimes, et al, 2004). 
Meraz prepared a formulation of HQ 4% with retinol 0.15% entrapped in micro-sponge 
reservoirs by two steps polymerization process in which  Eudragit RS 100 was dissolved in 
ethyl alcohol. Then, drug added to solution and dissolved under ultrasonication at 35 C. 
The inner phase was poured into the PVA solution in water (outer phase). Following 60 
min of stirring, the mixture is then filtered to separate the microsponges. The system was 
developed to release Hydroquinone gradually to prolong exposure to treatment and to 
minimize skin irritation. The safety and efficacy of this product were evaluated in a 12-
week open-label study. A total of 25 patients completed the study. Study end points 
included disease severity, pigmentation intensity, lesion area, and colorimetry assessments. 
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Adverse events also were recorded. Patients applied the microentrapped Hydroquinone 4% 
formulation to the full face twice daily (morning and evening), Patients were evaluated at 
baseline and at 4, 8, and 12 weeks. The microentrapped Hydroquinone 4%/retinol 0.15% 
formulation produced improvement at all study end points, the preparation was safe and 
effective.  
 Lin, et al, formulated an anhydrous emulsion system, without the aqueous phase, using 
deoxyArbutin, decomposes to hydroquinone in aqueous solutions.  
An anhydrous emulsion system could offer a stable vehicle for compounds that are 
sensitive to hydrolysis or oxidation. Therefore, to enhance the stability of deoxyArbutin in 
formulations, polyol-in-silicone as the basic formulation for investigation. The quantity of 
deoxyArbutin and the accumulation of hydroquinone at various temperatures analyzed 
through an established high performance liquid chromatographic (HPLC) method. 
The results indicated that water increased the decomposition of deoxyArbutin in the 
formulations and that the polyol-in-silicone, oil-based, anhydrous emulsion system 
provided a relatively stable surrounding for the deoxyArbutin that delayed its degradation 
at 25 °C and 45 °C. Moreover, the composition of the inner hydrophilic phase, containing 
different amounts of glycerin and propylene glycol, affected the stability of deoxyArbutin. 
the percentage of hydroquinone was calculated by the molar ratio of deoxyArbutin to 
Hydroquinone as 3 g of deoxyArbutin can completely decompose to 1.701 g of 
hydroquinone. 
 
Hans-Jorgebnu and Eckhard prepared Hydroquinone aqueous base using α, ß-cyclodextrin 
complexes, due to the ability of cyclodextrin complexes of prevention the oxidation of 
hydroquinone and offer greater stability. The results confirm that Hydroquinone 
cyclodextrin complexes offer a greater depigmentaion more than hydroquinone itself 
enhances skin- whitening effect. cyclodextrins derivatives are not a nutrient medium for 
microorganisms, As a result, the use of preservatives in formulations can be reduced, This 
is a further advantage of preparations. 
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Chapter three 
Aims of the study 
 
1. Development and characterization an alcohol-free microemulsion using promising 
tri-block co-polymer Poloxamer 188: polypropylene oxide polyethylene oxide 
polypropylene oxide (HO(C2H4O)80(C3H6O)27(C2H4O)80H) as a main surface 
active agent and other safe component.  
 
2. Developing and studying the phase behavior of tri-block co-polymer as main 
surfactant and in combination of co-surfactants/ co-solvent, with water. 
 
3. Develop the main phase behavior diagrams of tri-block co-polymer and with 
combination of co-surfactants/ co-solvent. 
 
4. Investigate the effect of addition of co-surfactants/ co-solvent on phase behavior of 
system containing tri-block co-polymer. 
 
5. Investigate the effect of temperature of the obtained phase behavior of tri-block co-
polymer.  
 
6. Use the prepared microemulsion in pharmaceutical application system to enhance 
the bioavailability of Atorvastatin calcium a poorly water soluble drug. 
 
7. Use the prepared microemulsion in cosmetics industry as suitable system to prepare 
Hydroquinone gel. 
 
8. Obtain the optimum microemulsion formulation to be further investigated on 
stability program. 
 
9. Investigate the optimum microemulsion formulation at accelerated stability 
conditions. 
 
10. Evaluate the stability results of the obtained system. 
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Chapter four 
Materials and method 
 
4.1 Materials 
 
Chemicals components used in this research for microemulsion preparation selected based 
on many properties as safety, compatibility, availability, ease of preparation and stability.   
 
Poloxamer 188 used as tri-block co-polymer surfactants for this research, the sample was 
donated by BASF Corp. (Israel) and was used as received from the manufacturer without 
any further Investigations. 
 
Lime oil samples were purchased from Frutarum Company (Haifa, Israel), the received 
samples analyzed for physical properties and results conforms to the manufacturer 
specification. 
 
Cremophore RH 40, polyoxyl 40 hydrogenated castor oil. 
The samples of Cremophor RH 40 purchased from BASF Corp. (Israel), the samples used 
as received without further investigation. 
 
Tween 80, Polyoxyethylene 20 sorbitan monooleate, Polyoxyethylene sorbitan fatty acid 
esters. The samples of Tween 80 purchased from Sapo Company (Israel) and used as 
received without further investigation. 
 
Propylene Glycol: the samples purchased from Gadot Company (Israel) and used as 
received without further investigation. 
 
Hydroquinone: samples of active material purchased from Parchem Company (USA), the 
content of the drug was 100.0 %. 
 
Atorvastatin Calcium: samples of active material purchased from Jiangsu Haohan 
Chemical Co.,Ltd ( China), the content of the drug was 100.5 % (Relative to standard). 
 
 
Butylated hydroxylToluene (BHT); samples purchased from Nova International Company 
(India), and used as received without farther investigation. 
 
Sodium Metbisulfite: Samples purchased from Sigma-Aldrich (Isreal) and used as received 
without farther investigation. 
 
Distilled water obtained from Quality Control lab of Jerusalem Pharmaceuticals. 
 
 
 
 
 
 
 
 
 
 
27 
 
4.2 Instruments and equipments 
 
Analytical balance (Acculab Vicon Vic-303). 
 
HPLC; Merck Hitachi Lachrom Elite HPLC System. 
 
Column: Octyl silane chemically bonded to totally porous silica, 25 cm length and internal 
diameter of 4.6 mm. 
Vortex mixer (mrc Laboratory Equipment VM-1000).  
Brookfeild Visvometer (Model A serial number 8534655, Massachusetts, 02346 USA). 
 
Polarizer microscope (Olympus). 
 
conductivity meter LF 538 (WTW). 
 
Refractometer mrc K7135. 
 
Incubator Feirrlaboo  FI 177. 
 
Refrigerator RF 675. 
 
pH meter: Hanna Instrument HI 1771. 
 
Cross polarizer, Shaker, Water bath, 10 mm glass test tubes with screw caps, Sonicator, 
Glass Beaker, Volumetric Flasks, Volumetric and graduated Pipettes.   
 
 
4.3 Procedure 
 
4.3.1. Constructing ternary phase diagram 
 
Sample of Tri-block copolymer surfactants  
 
Samples were prepared by weighing appropriate amounts of each component into 10 mm 
glass test tubes with screw caps at ambient condition. The volume of water was added drop 
wise  by titration then the samples were mixed by vortex then stand until equilibrate. 
Physical properties as clarity, color and number of phases obtained were detected 
organoleptically. Polarized microscope was used to detect anisotropy. Finally draw the 
phase diagram using OriginPro 7.5 program develop by OriginLab Corporation.  Each set 
of samples for each phase diagram system prepared with same procedure then the work 
was done with the same procedure and at 37⁰C. 
 
4.3.2. Application in Pharmaceutical Formulation: 
 
The constructed phase diagram of the studied system used to prepare formulation to 
enhance oral bioavalabilty of Atrovastatin poorly water soluble drug. Atorvastatin 
introduced to combinations of defined one phase region obtained in the constructed phase 
diagram for different systems. 
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4.3.3. Application in Cosmetics Formulation: 
 
The constructed phase diagram of the studied system used to prepare formulation to 
enhance solubility and stability of Hydroquinone.  
Hydroquinone active material introduced to a combination of defined one phase region 
obtained in the constructed phase diagram. 
 
 
 4.4 Stability Study: 
 
4.4.1. Accelerated stability study; 
 
The prepared samples studied at accelerated stability program the samples have been 
studied under stressed condition of temperature and Relative Humidity.  
The most common main stress conditions for stability indicating technique: are 40 ± 2ºC, 
75± 5% RH for all dosage forms and 5 ±3 ºC for gel and solutions dosage forms.  
 
 For pharmaceutical preparations the samples studied at 40 ± 2ºC, 75 RH for 3 months. The 
samples analyzed at time of preparation as  zero time and at the end of the period. 
 
The Cosmetics preparations the samples studied at 40 ± 2ºC, 75 RH relative humidity for 
14 days. The samples analyzed at time of preparation as  zero time and at the end of the 
period. 
 
4.4.2. Ambient stability study; 
 
Another set of prepared samples from cosmetics and pharmaceutical preparations studied 
at ambient conditions at room temperature for defined period of time exceeding 1 month. 
4.4.3 Determination of Drug Content: 
The content of atorvastatin determined by using HPLC chromatography within the 
following conditions: 
 
The chemical reagent used is: Acetonitrile, methanol, glacial acetic acid and water. 
Mobile Phase: 
The mobile phase prepared using a mixture of methanol, 1% (v/v  ( glacial acetic acid and 
acetonitrile (60:30:10). 
The Standard Preparation:  
Prepared by weighing a quantity of Atorvastatin calcium working standard equivalent to 
about 100 mg of Atorvastatin. Transfer to a 100-ml volumetric flask, complete to volume 
with methanol and mix. dilute 5 ml of this solution to 100 ml with water and mix. 
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The sample Preparation:  
The test samples prepared by transferring a quantity of preparation equivalent to about 100 
mg of Atorvastatin to a 100-ml volumetric flask, complete the volume with methanol. Then 
5 ml of this solution diluted to 100 ml with water. 
The proper chromatographic conditions: 
Detection Wavelength: 254 nm.  
Column: Octyl silane chemically bonded to totally porous silica, 25 cm length and internal 
diameter of 4.6 mm. 
Flow Rate: 1.5 ml/min.  
Injection volume: 20 µL 
Testing Procedure:  
Both the Standard Preparation and the Assay Preparation were separately injected into the 
Liquid Chromatograph. The chromatograms were record and the responses for the major 
peaks were measured.  
 
 
Finally the percentage of Atorvastatin calculated  using the following formula:  
                                            Area Under Peak of Assay Prep. 
% Atorvastatin = 
__________________________________________________ 
x 100% 
   Area Under Peak of Standard Prep. 
 
4.5. Methodology: 
To clarify and understand the behavior of Poloxamer 188 with lime oil, a phase diagram 
was prepared. Samples of poloxamer 188 and lime oil covering all the wanted area of 
phase diagram were weighted and drop wise water titration method used to reach the final 
volume. After each addition the samples were left for equilibrium time. Then the samples 
were carefully optically investigated for physical changes during the study period. Each 
sample was checked for phase separation, the phase diagram prepared depending on the 
data obtained after the end of study period. Just the one phase areas were plotted on the 
phase diagram and constructed for farther investigation. Areas with multi phases were not 
included in this study. Each system took 3-4 weeks to be finished. 
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To study the phase behavior of the tri-block copolymer with co-solvent, another set of 
samples after introducing Propylene glycol were prepared and the same procedure were 
followed.  
A process have been taken in order to clarify and characterize the behavior of the tri-block 
copolymer in presence of another surfactant, a third set of samples after introducing tween 
80 an  a co-surfactant were prepared and the results were obtained by the same procedure. 
A Fourth phase diagram system was prepared using another nonionic surfactant as co-
surfactant, a fourth set of samples after introducing cremophore RH40 were prepared and 
obtaining the phase diagram including clarify regions by the same procedure. As an 
effective application this phase diagram used to prepare a miceroemulsion system to 
enhance the solubility of atorvastatin calcium, and the prepared samples were studied 
under stability study. 
And finally for pharmaceutical application the effect of temperature on the phase behavior 
of the tri-block copolymer surfactant was investigated. The system of fourth phase diagram 
obtained after introducing Cremophore RH40 was investigated on 37ºC, the results were 
obtained and a final phase diagram was plotted. 
 The studied system used to prepared gel and solution of Hydroquinone aqueous base for 
topical use, the optimized formulations were determined and further examination were 
constructed.  
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Chapter five  
Results and discussion 
 
The component of each system have been chosen depending on many factors . oil was 
chosen as a best solvent for Active ingredients. Propylene glycol was chosen for its better 
solubility enhancement for Atorvastatin calcium more than polyethylene glycol 400 or 
glycerin. And as known for propylene glycol, it has a conditioning effect on skin and work 
as penetration enhancer. The other non ionic surfactants  as Tween 80 and Cremophore RH 
40 known for their safety, compatibility, stability and availability. 
   
5.1 Constructing the Phase diagram 
  
The phase diagram of ternary component obtained for each system as the following:   
The ternary phase diagram of poloxamer 188, water and lime oil at room temperature 
presented in figure (5.1). 
0.00 0.25 0.50 0.75 1.00
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0.50
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1.00
0.00
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Poloxamer 188
Water Lime Oil
L2
L1
Gel, Isotropic
  Slightly viscous,
          Isotropic
 
 
Figure 5.1: Ternary Phase diagram of three main components:  Poloxamer 188, Lime oil 
and water, the study obtained at room temperuture.  
 
As appears on Figure (5.1) the phase diagram of four one phase regoins were obtained, 
these regoins were  clear  homogeneous and isotropic under polarized light. The main 
differece betweeen them were in physical properties especialy  the viscosity. It was clearly 
varied from one reagoin to another. 
 
 The L1 regoin appears almost on the binary line between poloxamer and water mostly to 
the water rich reagoin, the phase is isotropic under polarized light. 
The  L2 regoin appears on the oil rich phase it was isotropic under polarized light its 
conductivity value was 9.6 µS. 
 
The slightly viscous regoin appears in the middle of the phase diagram was clear isotropic 
under polarized light its conductivity value was 37.5 µS, as the boundries of this regoin 
appears on the binary line for poloxamer and water  at below 50 % poloxamer content, and 
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depending on the isotropic properites, viscousity, conductivity and the position in phase 
diagram it is suggested to be normal Cubic Micellar [I1] regoin.(Alexandridis, et.al, 1998).  
 
The gel phase appears at aproximitly 50% of polymer concentration, it was isotropic under 
polarized light clear stif gel phase, according to its position and depending on the 
behaviuor of poloxamer and water on the binary line between water and poloxamer it is 
suggested to be normal Hexagonal phase, as it is known the hexagonal phase is shiny and 
anisotropic under polarized light, but these properties do not obtained within the 
investigated gel sample, it can be justificated  as the poloxamer is a weak nonionic 
surfactant and consist of blocks building units it is hard to show anisotropic properties 
especially when intorducing the oil, this led to loss the structure of Hexagonal make it 
more difficult to be identified by simple polarized light. 
 
The phase diagram of pluronic F127 with xylene constructed by Alexandridis, et.al. 1998 
indicated that the H1 phase apears after micellar cubic regoin as the poloxamer 
concentration increases,this note can help in clarifing the gel regoin. Also the gel phase 
appears at high poloxamer concentration (more than 50 %) and that agree with Wanaka, et 
al. 1999 results which indicated that at higher concentrations solutions with spherical 
micelles form in a first order transition, a transparent, optically isotropic, highly viscous, 
and elastic cubic phases are observed. The formation of this cubic explained as hard sphere 
interactions between the aggregates; with farther increasing concentrations transition to 
hexagonal and to lamellar phases occurred. 
 
As an effective step to enlarge the one phase regoins obtained in the prevois phase diagram 
appeared in Figure (5.1) propylene glycol added to lime oil with 50% in concentration, the 
effect of propylene glycol on the behavoir of the poloxamer 188 seems in the figure (5.2). 
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Figure 5. 2:  Ternary Phase diagram of three main components:  Poloxamer 188,Oil 
Mixture  (Lime oil: Propylene glycol 50:50) and water, the study obtained at room 
temperuture.  
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A four one phase homogenous clear and isotropic regions obtained in Figure ( 5.2). The 
effect of propylene glycol appears in the phase diagram by spreading the slightly viscous 
phase to be the largest region and larger than the phase obtained in the previous system 
obtained in figure (5.1).  
  
The liquid phase L1, the gel phase, the slightly viscous phase and L2 phase all these phases 
still obtained in the phase diagram appears in figure (5.2). As comparing the conductivity 
values of the obtained phases; the L2 conductivity value at room temperature was 11.6 µS 
and the slightly viscous region was about 50.5 µS, this shift in the conductivity values 
indicating the excess presence of water as transferring from L2 in oil rich corner to water 
rich corner and that confirm the effect of propylene glycol on the behavior of poloxamer. 
  
Depending again on the phase diagram of Pluronic F127 done by Ivanova. et. al. 2006 with 
propylene glycol, the phase diagram of Pluronic F127 and propylene glycol indicate the 
presence of three main phases the largest phase was I1 which exist between 18 to 65 % 
approximately of Pluronic F127 and H1 region between 68 – 78% of Pluronic F127. These 
results may help in identifying the gel phase and slightly viscous region as pluronic F127 
has 70% ethylene oxide and Poloxamer 188 has 80% of ethylene oxide, these notes may 
conclude to support the suggestions of these unknowns regions. 
 
 
Figure5.3: Ternary Phase Diagram of Pluronic 127, Propylene glycol and water 
 
When this was system used to solubilize atorvastatin calcium, the results were not so good 
The poloxamer alone could not give stable formulations. It seems helpful to add another 
surfactant to poloxamer 188, to enhance the preparation of stable and useful formula to be 
used as superior formulation to enhance the stability, solubility and bioavailability of 
poorly soluble drugs. Tween 80 is a non ionic surfactant and pharmaceutically compatible 
component to be used in pharmaceuticals, cosmetics and in food products. So Tween 80 
was introduced to the system and the phase behavior of the components studied , the results 
of the system appears in the figure (5.4). 
 
Ternary phase diagram of mixture of surfactant contains 75% of Poloxamer 188, 25% of 
Tween 80, oil mixture contains 50% lime oil and 50% propylene glycol obtained at room 
temperature a three clear one phase regions obtained as illustrated in figure (5.4). 
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Figure 5. 4: Ternary Phase diagram of three main components:  Surfactant Mixture 
(Poloxamer 188 : Twen 80,75: 25), Oil mixture (Lime oil: propylene glycol 50:50) and 
water, the study obtained at room temperuture. 
  
The main results were three homogenous clear and isotropic under polarized light one 
phase regions the narrow viscous phase, the intermediate slightly viscous phase and the 
wide L1 liquid phase, the liquid phase on water rich corner is Micelle phase L1 its 
conductivity value was 21.3 µs it was not viscous and isotropic.  
 
Tween 80 work as co-surfactant with percentage of 25%, the percentage of Poloxamer 188 
was 75% from the total amount of surfactant; it helps in increasing the solubilization 
capacity of the system, as appears in figure (5.4) much oil solubilized in the formulation 
more than in using poloxamer 188 alone. 
 
When using the system for preparation of Atorvastatin microemulsion, the obtained 
samples were not stable. Tween 80 forms cores emulsions which affect the shelf life and 
finally separation occurs. The gel phase does not appear in the figure that because the study 
includes the clear one phase regions only and exclude the multi phases regions. 
 
Another surfactant was used instead of Tween 80, a system using Cremophore RH40 co-
surfactant with the same ratio as in case of Tween 80, the phase diagram appears in figure 
(5.5) illustrate the result. 
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Figure 5.5: Ternary Phase diagram of three main components:  Surfactant Mixture 
(Poloxamer 188: Cremophore RH40 75:25), Oil Mixture ( Lime oil: propylen glycol 50:50) 
and water, the study obtained at room temperuture.  
 
Figure (5.5) shows a three main clear homogenous isotropic one phase regoins, using 
Cremophore RH40 increasing the solubilzation of oil more than in the case of Tween 80, 
escpically in L1 phase the water rich regoin. The conductivity values were 25.4 µs and 
16.4µs for L1 and the slightly viscous regoins, respictivly, these results indicating an 
excess in the presence of water as transfereing from water lean to water rich regoins in the 
phase diagram. 
 
Here the gel phase appearse again in the phase diagram,and again the slightly vicous regoin 
is suggested to be normal Cubic (I1) phase and the gel is suggested to be normal Hexagonal 
( H1) phase depending on the referece phase diagram of Pluronic F127 with xylene, and the 
peroperties of these regoins.  
  
In order to identify and characterize the effect of temperature on the phase behavior of the 
prepared mixture of surfactant and co-surfactant, Oil mixture in the last composition of 
figure (5.5), the system studied at 37 ºC and the phase diagram obtained illustrated in 
figure (5.6): 
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Figure 5.6: Ternary Phase diagram of three main components:  Surfactant Mixture 
(Poloxamer 188: Cremophore RH40 75:25), Oil Mixture ( Lime oil: propylen glycol 50:50) 
and water, the study obtained at 37C. 
 
The phase diagram in figure (5.6) appears three isotropic one phase regions as in figure 
(5.5) It is clear that the main difference in the two diagrams is the spreading of one phase 
regions to oil rich regions and that confirmed by the effect of temperature on non ionic 
surfactant.  
 
Figure (5.6) phase diagram indicates the behavior of poloxamer 188 and the effect of 
addition of co-solvent and co-surfactant to its behavior, and the effect of temperature was 
clearly obtained, increasing the temperature the solubility of surfactant in oil increases this 
results clarified by a large spreading of L1 phase isotropic region comparing with the L1 
phase in figure (5.5). All the one phase regions were isotropic under polarized light, and 
vary in viscosity. 
  
As comparing the results with the binary phase diagram of Poloxamer 188 appears in a 
published work for Wanaka, et al. 1994, there is a kind of compatibility of the results. 
 
 
 
Figure 5.7: phase diagram of the system Pluronic F68 [adapted from Wanaka, et al.1994] 
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The system shown above in figure (5.7) indicates the relation between increasing 
concentration of tri-block copolymer and temperature. The diagram indicates tow main 
regions the isotropic regions cover the largest area of the curve and the cubic V1 region 
appears on high polymer concentration at low temperature range.  
 
In a comparison with the results obtained by this research and the binary phase diagram 
appeared in figure ( 5.7) , there is a kind of compatibility between the results in obtaining 
the isotropic region of polymer at concentration up to 75% and at about 40 C , in which for 
this research the room temperature nor the stability study would not exceed this 
temperature, all the system studied in this research the isotropic regions obtained, and 
when introducing the co-solvent or co-surfactant to the system it changes the preference of 
poloxamer especially in the boundaries of the obtained region but the main isotropic region 
obtained in all of them with differing in physical properties specially the viscosity. Of 
course the system studied in this research differ on its component from figure (5.7) phase 
diagram of binary system of Pluronic F68 but it is seems to be good to compare the results 
with known behavior of the same tri block co-polymer.  
 
The Cubic V1 region obtained in the system Pluronic F68 obtained at polymer 
concentration start at about 50% on temperature exceeding 90C is a remarkable result its 
main properties is anisotropic under polarized light and has a high viscosity, this region is 
not obtained on the studied systems in this research. 
 
The main regions obtained from the systems studied in this research a clear L1, L2, normal 
cubic I1, and normal Hexagonal H1. The identification of hexagonal was slightly 
complicated, as introducing many components on the system with poloxamer the structure 
of hexagonal was loss, a kind of melting of the stiff hexagonal structure occurred which 
make it difficult to identify the anisotropic properties under  simple polarized light and 
more developed techniques have to be used as Small Angle X-ray Scattering (SAXS), 
NMR studies which are not available at the Lab where this work have been constructed.  
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5.2. Application in Pharmaceutical Formulation: 
  
Enhancement bioavailability of Atorvastatin: 
 
 For Pharmaceuticals applications the prepared system used to enhance the solubility and 
bioavailability of poorly water soluble and low oral bioavailability of Atorvastatin. 
Atorvastatin calcium used as salt form of active ingredient as it’s the known form of active 
material in oral tablet. 
 
5.2.1. Pre-formulation: 
 
A series of formulation were prepared using lime oil as solubilizer, Poloxamer 188 as a 
main surfactant and propylene glycol as co-solvent and Tween 80 and Cremohpor RH40 as 
co-surfactants. The prepared formulation listed in table (5.1): 
 
Table (5.1-A): Composition for various formulations containing Atorvatstain.  
 
Component (w/w %) F1 F2 F3  F4 F5 F6 
Atorvastatin Calcium 0.49 0.63 0.59 0.66 1.54 1.71 
Lime Oil 9.3 9.32 23.53 16.56 30.77 34.19 
Propylene glycol 9.3 9.32 23.53 16.56 30.77 34.19 
Poloxamer 188 31.1 30.43 8.24 23.18 10.77 11.97 
Tween 80 0 0 0 0 0 0 
Cremophor RH40 12.4 13.03 35.29 9.93 4.62 5.13 
Water 37.4 37.27 8.82 33.11 21.53 12.81 
 
Table (5.1-B): Composition for various formulations containing Atorvatstain.  
 
Component  F7 F8 F9 F10 F11 F12 
Atorvastatin Calcium 1.4 1.2 0.80 1.6 4.8 1.4 
Lime Oil 7.0 14.7 31.7 31.5 11.9 16.4 
Propylene glycol 7.0 14.7 31.7 31.5 11.9 16.4 
Poloxamer 188 42.3 20.6 11.9 11.8 17.9 32.9 
Tween 80 0 0 4.0 3.9 6.0 0 
Cremophor RH40 14.1 8.8 0 0 0 0 
Water 28.2 40 19.8 19.7 47.6 32.9 
 
Table ( 5.1) describe 12 formulation prepared as a main formulation for Atorvastatin, all 
were prepared simultaneously and  at same conditions of  temperature and humidity. 
  
5.2.2. The Specification of the Finished Product: 
 
The prepared sample ranging from F1 to F12 prepared at room temperature the 
specification and results illustrated in table (5.2): 
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Table (5.2-A): Results at Time of Preparation ( Zero Time). 
 
Test  Limit F1 
 
F2 
 
F3  F4 F5 F6 
Color Colorless - yellowish Conform Conform Conform Conform Conform Conform 
Odor Lime Lime Lime Lime Lime Lime Lime 
Clarity Clear Clear Clear Clear Turbid Turbid Turbid 
Appearance Solution Solution Solution Solution Solution Solution Solution 
pH 6.0 – 8.0 6.8 6.7 6.8 6.8 6.8 6.8 
Viscosity NMT 10000 cps 1700 1500 2000  2000 2500  1200  
Date 8\12 8\12 7\12 7/12 5\12 7\12 
 
Table (5.2.B): Results at Time of Preparation ( Zero Time). 
 
Test  Limit F7 F8 F9 F10 F11 F12 
Color Colorless - yellowish Conform Conform bluish bluish bluish white 
Odor Lime Lime Lime Lime Lime Lime Lime 
Clarity Clear clear Turbid clear clear Turbid Turbid 
Appearance Solution Solution Solution Solution Solution Solution Suspension 
pH 6.0 – 8.0 6.8 6.8 6.8 6.8 6.8 6.8 
Viscosity NMT 10000 cps 25000 2000 500 500  1200  500  
Date 8\12 8\12 7\12 7/12 7\12 7\12 
 
As Appeared in table (5.2) some of the prepared formulation fail to obtain the main 
specification of the finished product, specially the physical appearance, F4, F5, F6, F8, F11 
and F12 for turbid solution which will lead to precipitation after a period of time so these 
formulation were excluded.  
 
5.2.3. Stability Result at Ambient Condition: 
 
The prepared formulation stored at room temperature and the result illustrated in the tables 
below: 
 
Table (5.3-A): Stability Results at Ambient Conditions (Room Temperature). 
 
Test Limit F1 F2 F3 F4 F5 F6 
Color Colorless - 
Yellowish 
Conform Conform Conform Conform Conform Conform 
Odor Lime Lime Lime Lime Lime Lime Lime 
Clarity Clear Clear Clear Turbid Turbid Turbid Turbid 
Appearance Solution Solution Solution Solution Suspension Suspension Suspension 
pH 6.0 -8.0 6.8 6.7 6.8 6.8 6.8 6.8 
Viscosity NMT 3000 cps  1500 1300  1800 1700 3000 1000 
Date 11\12 10\12 10\12 9\12 9\12 10\12 
NMT: Not More Than. 
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Table (5.3-B): Stability Results at Ambient Conditions (Room Temperature). 
 
Test Limit F7 F8 F9 F10 F11 F12 
Color Colorless - 
Yellowish 
Conform Conform Conform Conform Conform Conform 
Odor Lime Lime Lime Lime Lime Lime Lime 
Clarity Clear Turbid Turbid Turbid Turbid Turbid Turbid 
Appearance Solution Solution Suspension Solution Solution Suspension Suspension 
pH 6.0 -8.0 6.8 6.8 6.8 6.8 6.8 6.8 
Viscosity NMT 3000 cps  27000  1700  700 600  1300  300 
Date 11\12 11\12 9\12 9\12 11\12 11\12 
 
 Table (5.3) describe the results of formulations stored at room temperature after a period 
of time ranging from 2 -3 months, the formulations numbered as F3, F4, F5, F6, F7, F8, 
F9, F10, F11 and F12 show significant change in the physical properties of the finished 
product, so these set of formulation could not be constructed to accelerated stability study 
and have to be excluded. 
 
5.2.4. Accelerated Stability Study: 
 
Samples from F1 and F2 studied at 40 ± 2C; RH 75% for 3 months, there was no 
significant change during the mentioned study period. 
 
Table (5.4): Stability Results at Accelerated Conditions.  
 
Test Limit 0 Time 3 months 
F1 F2 F1 F2 
Color Colorless - Yellowish Con. Con. Con. Con. 
Odor Lime fragrance  Lime  Lime  Lime  Lime  
Clarity Clear Clear Clear Clear Clear 
Appearance Solution Sol. Sol. Sol. Sol. 
pH 6.0 - 8.0 6.8 6.7 6.8 6.8 
Viscosity NMT 10000 cps 1500  1300  1400  1200 
Assay:  
Atorvastatin calcium 
 
90.0 – 110.0 % 
 
105.0 % 
 
97.0 % 
 
103.0 % 
 
98.0 % 
Degradation NMT 2.0 % UN UN UN UN 
NMT: Not More Than. UN: Undetected: below detection limit. 
 
Table (5.4) describe the stability results of Formulation numbered as F1, F2 studied at 
accelerated stability of temperature and relative humidity for 3 months, the result indicate 
there is no significant  change in the physical and chemical properties within the mentioned 
study period.  
 
5.2.5. Stability at Refrigerator 5 ± 3ºC: 
 
The prepared samples stored at temperature range of 2-8C and the results illustrated in the 
table below: 
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Table (5.5): Stability Results at Refrigerator. 
 
Test Limit 0 Time 3 months 
F1 F2 F1 F2 
Color Colorless - Yellowish Conform Conform Conform Conform 
Odor Lime fragrance  Lime  Lime  Lime  Lime  
Clarity Clear Clear Clear Clear Clear 
Appearance Solution Solution Solution Solution Solution 
pH 6.0 - 8.0 6.8 6.8 6.8 6.8 
Viscosity NMT 10000 cps 1500  1300  1100  1000 
Assay:  
Atorvastatin calcium 
 
90.0 – 110.0 % 
 
105.0 % 
 
97.0 % 
 
103.0 % 
 
98.0 % 
Degradation NMT 2.0 % UN UN UN UN 
NMT: Not More Than. UN: Undetected: below detection Limit. 
 
5.2.6. Content of drug: 
As atorvastatin microemulsion dosage forms not established by any pharmaceutical 
reference the content limits were in housed designed to be 90.0 to 110.0 % of the labeled 
content, all the results were within the designed range. 
 In order to examine the effectiveness of test method a blank sample of the formulation 
were prepared without the active pharmaceutical ingredient and analyzed within the same 
procedure the results were complies with what expected, the peak of atorvastatin was not 
obtained on the chromatogram for blank samples. 
5.2.7. Identification Test: 
For identification and validation purposes the chromatograms obtained from prepared 
samples were compared, there were compliance between the samples of standard 
preparation and the test preparation. The following figures identify the obtaining 
chromatograms: 
 
Figure (5.8): the chromatogram of standard preparation. 
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Figure (5. 9) : the chromatogram of Sample preparation. 
 
 
Figure (5.10) : the chromatogram of blank preparation. 
As appear in the obtained chromatograms the retention time of Atorvastatin peak in the 
chromatogram of the sample Preparation corresponds to that of the Standard Preparation 
and there are no peaks on the same retention time on the blank preparation. 
The noise peak appears in the beginning of the chromatogram treated as unreturned and 
have no effect on the values of area under the main peaks of the active ingredient and this 
result is very important for validation studies which means that the supplied test method in 
selective for the active ingredient.  
5.2.8. pH Test: 
The limit of pH has designed in house to be (6.0 – 8.0) 
The pH = 6.8 on zero time and at the end of the mentioned study period there was no 
significant change on the pH value of Atorvastatin microemulsion. 
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As mentioned ealier the formulation have to have a pH value above 4.5 at least 5.5 which 
is higher than pKa of Atorvastatin. The preparation formulations has pH value 6.8 and 
maintain within the same range, it is a great benefit and seems promising in bioavailability 
enhancement. 
5.2.9. Dilution study:  
 
The prepared samples tested for dilution using different solvent: water, 0.1 N HCl, 6.8N 
Phosphate buffer, the results illustrated in table below: 
 
Table (5.6): Stability Results for dilution study at Room Temperature. 
 
Test:  Limit F1 F2 
Dilution with H2O ( 1ml to 100ml) 
Color Colorless Colorless Colorless 
Clarity Clear Clear Clear 
Stability  Up to 5 hours Up to 12 hours Up to 12 hours 
Dilution with HCL 0.1N ( 1ml to 100ml) 
Color Colorless Colorless Colorless 
Clarity Clear Clear Clear 
Stability  Up to 5 hours Up to 12 hours Up to 12  hours 
Dil. with Phosphate Buffer 6.8 N ( 1ml to 100ml) 
Color Colorless Colorless Colorless 
Clarity Clear Clear Clear 
Stability  Up to 5 hours Up to 12 hours Up to 12 hours 
 
The dilution study reflect the behavior of prepared formulation as if it is taken orally and 
facing the fluids during Digestion system, firstly the stomach acidic environment, and then 
to Intestine basic environment. 
  
The stability of the formulation  during the dilution and for a period exceeding 12 hours 
indicate that the drug is stable within the period in which the drug stayed at stomach or 
Intestine. And these issue are critical steps determine the efficiency of the drug. 
 
5.2.10. Stability Results:  
 
Chemical stability: 
 
There is no significant change in the active ingredient on the samples stored at room 
temperature, at 5 ± 3C and at 40 ± 2C, 75% RH in all samples for the mentioned study 
period and conditions. 
 
Physical properties: 
 
There is no significant change in the color, odor, pH, and appearance on the samples stored 
at room temperature, at 5 ± 3C and at 40 ± 2C, 75% RH for the mentioned study period 
and condition. 
 
The study  show that Atorvastatin microemulsion preparation is stable during the study 
period, no defects were observed during the mentioned study period with the ambient or 
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stress conditions, the pH stability indicate that the preparation still be stable and compatible 
when taken orally and will not decompose by the effects of low acidic pH. 
Atorvastatin calcium as an active pharmaceutical ingredient has a very low solubility at 
acidic pH or phosphate buffer, but the prepared Atorvastatin microemulsion can freely 
soluble in acidic pH of 0.1N HCl, phosphate buffer and water, above that the stability of 
the dilution assure that taken dosage will stay safe and could reach the Intestine to be 
absorbed effectively.  The dosage of Atorvastatin microemulsion may have effectiveness 
more than ordinary labeled dosage of marketed oral tablet, which may help in determine 
the low dose of Atrovastain to be less than 10mg. 
 
5.3. Applications in cosmetics:  
 
For cosmetics applications the prepared system used to enhance the stability and solubility 
of Hydroquinone to develop a hydroquinone gel for Topical uses. 
 
5.3.1. Preformulation:  
 
A series of formulations were prepared using Lime oil as a solvent, Poloxamer 188 as a 
main surfactant and propylene glycol as co-solvent. The main dosage form prepared 
consisting of solutions and gel for topical application. 
 
The formulation prepared listed in table (5.7): 
 
 Table (5.7): Composition for various formulation containing Hydroquinone.  
 
Component  Qty in grams for 100 gram of microemulsion 
F15 F16 F17 F18 
Hydroquinone 1.900 2.1 2.10 2.10 
Lime Oil 6.375 6.375 6.25 12.5 
Propylene glycol 6.375 6.375 6.25 12.5 
Poloxamer 188 56.00 56.00 37.5 25.0 
Sodium metabisulfite 0.5000 0.5000 0.500 0.500 
BHT 0.1000 0.1000 0.100 0.100 
Water 31.25 31.25 50.0 50.0 
  
Table (5.7) illustrated the main formulations preprared for hydroquinone  gel and solution, 
numbers as F15, F16, F17 and F18, all the prepared samples prepared simultaneously at the 
same conditions of temperature and humidity and constructed for further investigations. 
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 5.3.2. Specification of Finished Product: 
 
The specifications and zero- time result for samples at room temperature illustrated in the 
table below:  
 
Table (5.8): Results at Time of preparation (Zero Time). 
 
Test Limit F15 F16 F17 F18 
Color Colorless Colorless Colorless Colorless Colorless 
Odor Lime fragrance Lime  Lime  Lime Lime  
Appearance Soft semisolid  Conform Conform Conform Conform 
Clarity Clear Clear Clear Clear Clear 
Viscosity NMT 20000 cps 16000  15000 8000 6000 
Date 25\10\12 25\10\12 25\10\12 25\10\12 
NMT: Not More Than. 
 
Table (5.8) describe the specifications of the prepared formulations numbered as F15, F16, 
F17 and F18, and indicate that there is no significant change within the prepared 
formulations.   
 
 
 
5.3.3. Stability Result at Ambient Condition:   
 
The prepared samples stored at room temperature for 1 month, the results illustrated on 
table (5.9):  
 
Table (5.9): Stability Results at Ambient Conditions (Room Temperature) for 1 month. 
 
Test Limit F15 F16 F17 F18 
Color Colorless Colorless Colorless Colorless Colorless 
Odor Lime fragrance Lime Lime Lime Lime 
Appearance Soft semisolid  Conform  Conform  Conform  Conform  
Clarity Clear Clear Clear Clear Clear 
Viscosity NMT 20000 cps 16500  16400 8200 5800 
Date 25\11\2012 25\11\2012 25\11\2012 25\11\2012 
 
Table (5.9) indicated that there is no significant change within the properties of the samples 
stored at room temperature for 1 month. 
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5.3.4. Accelerated Stability Study: 
 
The prepared samples stored at 40 ± 2 C for 14 days, the results are in tables(5.10): 
 
Table (5.10): Stability result at Accelerated Conditions (40 ± 2 C, 75% RH) for 14 days. 
 
Test Limit F15 F16 F17 F18 
Color Colorless Colorless Colorless Colorless Colorless 
Odor Lime fragrance Lime Lime Lime Lime 
Appearance Soft semisolid  Conform  Conform  Conform  Conform  
Clarity Clear Clear Clear Clear Clear 
Viscosity NMT 20000 cps 15000  15000 7500 6000 
Date 6\11\2012 6\11\2012 6\11\2012 6\11\2012 
 
Table (5.10) indicated that there is no significant change within the properties of the 
samples stored at accelerated conditions for 14 days. 
 
5.3.5. Stability at Refrigerator 5 ± 3C: 
 
The results of the samples stored at temperature range (2 – 8)C for illustrated in table 
(5.11) 
 
 Table (5.11): Stability result at Refrigerator 5 ± 3 C for 1 month. 
 
Test Limit F15 F16 F17 F18 
Color Colorless Colorless Colorless Colorless Colorless 
Odor Lime fragrance Lime Lime Lime Lime 
Appearance Soft semisolid  Conform  Conform  Conform  Conform  
Clarity Clear Clear Clear Clear Clear 
Viscosity NMT 20000 cps 10000 12000 5000 5000 
Date 25\11\2012 25\11\2012 25\11\2012 25\11\2012 
 
 Table (5.11) indicated that there is no significant change within the properties of the 
samples stored at refrigerator for 1 month. 
 
 
5.3.6. pH Test: 
 
The range of pH for both gel and solution of preparations was ( 6.5 – 7.0) 
All the prepared samples tested at zero time and at the end of study period was not 
exceeding the limit of pH at all storage conditions. 
 
5.3.7. Stability Results:  
 
Physical properties: 
 
There is no significant change in the color, odor, appearance, and pH on the samples stored 
at room temperature, at 5 ± 3C and at 40 ± 2C, 75% RH for the mentioned study period. 
 
There is no significant change in the samples during the mentioned study period which 
indicates that an easily prepared , effective, stable, compatible and safe of Hydroquinone 
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topical preparations are stable for at least 6 months and that is in accordance with approved 
guidelines for cosmetics registration on Palestinian ministry of health based on 
International Regulations. 
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Chapter Six 
Conclusion 
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Chapter six  
6.1 Conclusion 
 
Poloxamer 188 triblock copolymer has a superior properties make it a promising material 
in different field of application, this research supplied unique results about poloxamer 188 
tri-block copolymer. 
 
The isotropic regions obtained from phase behavior of poloxamer 188 with lime oil 
indicate the main guidelines in spreading the study to investigate the effect of co-solvent, 
other nonionic surfactants and temperature on the poloxamer behavior. 
 
Poloxamer 188 has 80% ethylene oxide, this unique properties make it more hydrophilic, 
and that noticed by the behavior of poloxamer toward preferable water solubility. 
 
Addition Propylene glycol was helpful. It works as a surfactant and help in spreading the 
one isotropic region on the phase diagram, as discussed before propylene glycol molecule 
exist between hydrophilic block and hydrophobic blocks of the copolymer this effect make 
it work as a small surfactant beside tri-block copolymer. 
 
The behavior of poloxamer 188 with Tween 80 was remarkable the isotropic one phase 
region seems promising to many field of industry, pharmacy, cosmetics and food, because 
the compatibility and safety of Tween 80, but Tween 80 make vigorous emulsion when 
applied to atorvastatin calcium microemulsion which reflected as a slightly turbid bluish 
emulsions, which finally conclude to separation of the preparation, this results lead to 
looking for other compatible nonionic surfactant. The Cremophore RH40 was the desired 
one. 
 
The phase behavior of addition of cremophore RH40 to main system of poloxamer 188, 
Lime oil and propylene glycol gives a promising results and a formulation section of 
superior various preparations. 
 
The sensitivity of poloxamer as nonionic surfactant appears clearly on the phase diagram 
of poloxamer 188 and cremophore RH 40 as surfactant, Lime oil and propylene glycol as 
oil phase, there is  a clear shift and spreading to the isotropic one phase regions to oil rich 
corner. And the obtained phase diagram supply the research a strength and reliable results 
especially in pharmacy. Temperature of 37C is the body temperature it is much helpful to 
know the changes that may occur for the prepared formulation when applied as oral dosage 
forms.  
 
Atrovastatin active ingredient is very important drug as lipid lowing agent, it used 
worldwide by differing age and dosage, the lowest dose supplied as oral tablet of 10mg, 
there is no known dose of atorvastatin microemulsion till the time of this research, the 
supplied research supply stable and applicable microemulsion formulation of 5 and 7.5 mg 
of atorvastatin calcium per ml of preparation. 
  
Hydroquinone active ingredient as bleaching and anti-aging agent supplies as creams, gel, 
and solution for topical use, it supplied up to 5% in pharmaceutical products and up to 2% 
as OTC products the main issue is the stability of the product. 
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The research supplies a stable formulation of 2% hydroquinone gel for topical preparation. 
The unique properties of the hydroquinone gel that each component has different and 
important mission, relating to oil phase, Lime oil is superior components in facial products 
specially sunscreen and as perfuming material of the gel, the other component propylene 
glycol forming as a co-solvent and preservative agent material even its use in higher 
percentage in topical preparation  for this purpose, there is a great benefit for using 
propylene glycol related to its biocompatibility, it works as penetration enhancer on skin. 
Hydroquinone gel for topical use could be treated as a brand formulation in cosmetics 
branch for its new component, stable, safe and compatible properties. Even in the research 
there is stable formulation for hydroquinone solution. 
 
The research of formulation of hydroquinone has been restricted for only one system of the 
main studied system, and that is a great benefit in formulation. It’s important to perform a 
product with minimum cost especially when the research treated as industrial scale, it is 
much better to perform a stable, effective, safe, high quality and low cost product than 
consuming a lot of component and introducing an extra costing manufacturing steps or 
equipment as heating, cooling. 
  
This research provide unique properties of formulation depending on tri-block copolymer 
behavior, each  phase diagram could be treated as a main guideline and as a map identify 
the prosperities and boundaries of each region, in which  could be used as a safe selection 
for formulation. 
 
 
6.2 Future Work 
 
The research present a golden reliable result which can be used as a true real project and 
apply as Industrial production scale, work may farther investigated on Atorvsatatin 
microemulsion, investigation may done on using the preparations as soft gelatin capsule 
dosage form and clinical studies may accomplished, relating to hydroquinone topical gel a 
farther investigation may apply on sensitivity of skin and permeation of dug.  
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يحضر من مكون مائي ومكون زيتي تربطهما مادة فعالة على السطوح تعرف ) noislumeorcim(  المستحلب
هذة  أهممن , هناك عدة نظريات تتعلق بدراسة المستحلب من حيث التحضير والخصائص والثباتية, )tnatcafruS(
من استعمال  الأهميةفي  الأولىالدرجة  أن إذ, وجود المادة الفعالة على السطوح ونسيتها بأهميةالنظريات ما يتعلق 
بين مكونات المستحلب لتتم عملية )  noisneT laicafretnI(المادة الفعالة على السطوح هو تخفيف التوتر السطحي 
الثباتية وسهولة التحضير ) noislumeorcim(مميزان المستحلب أهممن . استهلاك للطاقة أو إضافاتالانسجام دون 
 التركيب الكلي فتعطيه الشكل الفيزيائي الشفاف  ينالتي تب على المستوى المجهري الدقيق وصغر حجم الجزيئات
متقدمة ومتطورة يمكن تبسيط فكرة  أدواتوالمتناهي في الصغر ويتم التعرف والكشف عن هذة الخصائص باستعمال 
للأجزاء الدقيقة المكونة للمستحلب عند  الأساسيةعملها على اعتمادها على زاوية انعكاس الضوء عن المكونات 
 .تعريضها لضوء بصفات وخصائص معينة
 
الحديثة  التي يستعمل في كافة مناحي الصناعة  الأنظمة وأوسع أفضللمستحلب جعلته من الخصائص التي تميز ا إن
 .والإلكترونيةوالعلم خاصة الصناعات الدوائية والتجميلية 
وتعرف , المواد الفعالة على السطوح التي تستخدم في تقليل التوتر السطحي لمكونات المستحلب أهمالبوليمرات من 
جزيئات ضخمة تتكون من لبنات بنائية تعرف الواحدة منها باسم مونمر وتترتب هذة المونمرات  البوليمرات على انها
واحيانا , بطريقة معينة وبروابط بينية تعطي الشكل العام للبوليمر من حيث الحجم والكتلة الجزيئية والخصائص القطبية
 .الاستعمالات التي يدخل فيها
 
عبارة عن وحدة بناء ثلاثية التركيب , بوليمر ثلاثي البنية ملبوليمر يعرف باستركز الدراسة على الخصائص الدقيقة 
من مادة  وطرفين محيطين بالنواة ذات خصائص قطبية من مادو بوبلين اوكسيد وتتكون من نواه طبيعتها غير قطبية
السوق لكافة الاستخدامات وتعرف بعدة انواع من حيث الخصائص الكيميائية والفيزيائية ومتاحة في .  ايثلين اوكسيد
 .الصناعية والطبية والتجميلية والالكترونية والجراحية
 
هذة البوليمرات  الى طبيعة تكوينها من اللبنات الاساسية حيث تعطيها خصائص وتكون يعود التميز في خصائص  
شفاف وصلب وطبقات  طبقات على المستوى المجهري الدقيق تظهر بشكل فيزيائي متنوع من هذة الطبقات تكوين جل
اخرى تترواح في اللزوجة والشفافية وطبعا في الخصائص الكيميائية اذ ان لهذة البوليمرات الثلاثية القدرة على الذوبان 
ويتم دراسة المادة الفعالة على السطوح  .وتكوين تنوع في التركيب في كافة انواع المحاليل القطبية وغير القطبية
 .))margaid esahpباستخدام دراسة ) sesahp erutcurtsorciM )ات وفعاليتها في تكوين طبق
 
 البوليمرات الثلاثية يعرف باسم بوليكسيمير المواد الفعالة على السطوح من تركز الدراسة على استخدام نوع معين من
 esahp (في  تم الحصول عليها) esahp( حيث تم دراسته وتحديد الخصائص والصفات لكل طبقة ,  118
 deziraloP(( بالمراقبة الدقيقة لاي تغيرات تظهر خلال تحضير العينات وفحص العينات تحت الضوء , )margaid
 erohpomerC ,08 neewTتخفيف التوتر السطحي مثل مواد  يوتم دراسة تاثير اضافة مواد مساعدة ف.  thgil
الحرارة  تأثيرمنفصلة وكذلك اختبار  أنظمةفي   وكذلك مواد تساعد على الذوبان مثل مادة البروبلين جلايكول 04HR
 .على تصرف مادة البولكسمير
 
لتحسين المساعدة  الأخرىالتي تم العمل عليها في الدراسة استخدام صفات وخصائص البولكسمير مع المواد  الأهداف
 .فاعلية دواء الاتروفاستيتن والهيدروكينون
المستعملة للكوليسترول في العالم  الأدوية أكثرسترول في الدم وهو من الاتورفاستيتين دواء يؤخذ لضبط مستوى الكولي
المشكلة . ملغم 11ملغم و 10, ملغم 10, ملغم18ويؤخذ بجرعات دوائية بشكل حبوب صلبة تركيز المادة الفعالة فيها 
ة مقارنة مع الكمية التي التي تواجه المريض في هذا الدواء ان نسبة الدواء التي يتم امتصصها في الجسم قليل الأساسية
على البولكسمير  أساسيلذلك تم العمل على تحضير مستحلب يعتمد بشكل  .تؤخذ بالجرعة ونسبة قليلة جدا تصل للدم
كمادة مذيبة  liO emiLكمادة مساعدة ومادة زيت الليمون   04HR rohpomerCكمادة فعالة على السطوح ومادة 
 .أساسيومادة بروبلين جلايكول كمادة مساعدة  والماء كمذيب 
وتمت دراستها على , تم تحضير عينات بعدة تراكيز من المواد المذكورة  وتحوي اكثر من تركيز من المادة الفعالة
م  0± 10ك على م ودرجة حرارة الغرفة وكذل 1-0ظروف حرارة ورطوبة مختلفة تتراوح بين درجة حرارة الثلاجة 
 .وكانت النتائج ايجابية لأكثر من تركيبة شهور 3لفترة تتراوح من شهر حتى , %75ورطوبة نسبية 
 75
 
ون كمادة مبيضة بالدرجة الالولى يستعمل الهيدروكين, المادة الدوائية الأخرى التي تم العمل عليها مادة الهيدروكينون
في المجال التجميلي ويعرف في السوف باشكال جل % 0لا تتعدى  في المجال الطبي وتراكيز% 7وبتراكيز لا تتعدى 
 .وكريم ومحلول للاستعمال الخارجي على الجلد
تم , المشكلة الاساسية التي تواجه العمل على هذا المستحضر أن ثباتيته حساسة جدا ويعمل بحذر خاصة من الضوء  
وتتكون , و للاستعمال التجميلي% 0ن بتراكيز تصل  العمل في الدراسة على تحضير عينات من مستحضر الهيدروكينو
من مواد البولكسمير والماء وزيت الليمون ومادة البروبلين جلايكول وتم دراسة الثابتية للعينات التي تم تحضيرها  على 
, %75م ورطوبة نسبية  0± 10م ودرجة حرارة الغرفة وحرارة  1 – 0ظروف حرارة ورطوبة تتراوح بين الثلاجة 
 .يوم وكانت النتائج جيدة جدا  13 – 08فترة تتراوح من ل
